Cargando…

Targeted genome and epigenome editing using engineered TALE and CRISPR/Cas9 technologies

Detalles Bibliográficos
Autor principal:	Gersbach, Charles A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304373/ http://dx.doi.org/10.1186/1744-8069-10-S1-O4

Ejemplares similares

CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome
por: Klann, Tyler S., et al.
Publicado: (2017)

Highly Specific Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements
por: Thakore, Pratiksha I., et al.
Publicado: (2015)

Epigenome editing by a CRISPR/Cas9-based acetyltransferase activates genes from promoters and enhancers
por: Hilton, Isaac B., et al.
Publicado: (2015)

Predicting the effect of CRISPR-Cas9-based epigenome editing
por: Batra, Sanjit Singh, et al.
Publicado: (2023)

Front-line of genome editing technology for animal cell engineering
por: Sakuma, Tetsushi
Publicado: (2015)

Optimization of genome editing through CRISPR-Cas9 engineering
por: Zhang, Jian-Hua, et al.
Publicado: (2016)

Bioethical issues in genome editing by CRISPR-Cas9 technology
por: AYANOĞLU, Fatma Betül, et al.
Publicado: (2020)

Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector
por: Kabadi, Ami M., et al.
Publicado: (2014)

Targeted DNA demethylation of the Fgf21 promoter by CRISPR/dCas9-mediated epigenome editing
por: Hanzawa, Nozomi, et al.
Publicado: (2020)

Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

Efficient Genome Editing Using CRISPR/Cas9 Technology in Chicory
por: Bernard, Guillaume, et al.
Publicado: (2019)

Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme
por: Al-Sammarraie, Nadia, et al.
Publicado: (2021)

CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review
por: Syding, Linn Amanda, et al.
Publicado: (2020)

Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing
por: Leibowitz, Mitchell L., et al.
Publicado: (2021)

Multiplex CRISPR/Cas9-Based Genome Editing for Correction of Dystrophin Mutations that Cause Duchenne Muscular Dystrophy
por: Ousterout, David G., et al.
Publicado: (2015)

Overcoming the Limitations of CRISPR-Cas9 Systems in Saccharomyces cerevisiae: Off-Target Effects, Epigenome, and Mitochondrial Editing
por: Sato, Genki, et al.
Publicado: (2023)

CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications
por: Cheng, Hao, et al.
Publicado: (2021)

Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators
por: Polstein, Lauren R., et al.
Publicado: (2015)

Correction to: Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

CRISPR/Cas9 genome editing technology in filamentous fungi: progress and perspective
por: Song, Runjie, et al.
Publicado: (2019)

Application progress of CRISPR/Cas9 genome-editing technology in edible fungi
por: Zhang, Yan, et al.
Publicado: (2023)

Hypercompact CRISPR–Cas12j2 (CasΦ) enables genome editing, gene activation, and epigenome editing in plants
por: Liu, Shishi, et al.
Publicado: (2022)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

CRISPR/Cas9 and TALE: beyond cut and paste
por: Deng, Liping, et al.
Publicado: (2015)

Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)

Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015)

CRISPR/Cas9: Transcending the Reality of Genome Editing
por: Chira, Sergiu, et al.
Publicado: (2017)

Genome Editing in Cotton with the CRISPR/Cas9 System
por: Gao, Wei, et al.
Publicado: (2017)

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021)

CRISPR–Cas9 Based Bacteriophage Genome Editing
por: Zhang, Xueli, et al.
Publicado: (2022)

CRISPR/Cas9 genome editing for neurodegenerative diseases
por: Nouri Nojadeh, Jafar, et al.
Publicado: (2023)

Precision genome editing in plants: state-of-the-art in CRISPR/Cas9-based genome engineering
por: Wada, Naoki, et al.
Publicado: (2020)

CRISPR/Cas9 Genome-Editing Technology and Potential Clinical Application in Gastric Cancer
por: Almeida, Renata Sanches, et al.
Publicado: (2022)

CRISPR-Mediated Epigenome Editing
por: Enríquez, Paul
Publicado: (2016)

Edition of TFAM gene by CRISPR/Cas9 technology in bovine model
por: de Oliveira, Vanessa Cristina, et al.
Publicado: (2019)

An Insight into Modern Targeted Genome-Editing Technologies with a Special Focus on CRISPR/Cas9 and its Applications
por: Akram, Fatima, et al.
Publicado: (2022)

Engineering of CRISPR-Cas12b for human genome editing
por: Strecker, Jonathan, et al.
Publicado: (2019)

Improved genome editing by an engineered CRISPR-Cas12a
por: Ma, Enbo, et al.
Publicado: (2022)

Deciphering Plant Chromatin Regulation via CRISPR/dCas9-Based Epigenome Engineering
por: Dubois, Annick, et al.
Publicado: (2021)

S255: CELLULAR SENESCENCE AND INFLAMMATORY PROGRAMS ARE UNINTENDED CONSEQUENCES OF CRISPR-CAS9 GENE EDITING IN HEMATOPOIETIC STEM AND PROGENITOR CELLS
por: Conti, Anastasia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_prjpits0dsjso7l8u3uujjuifk